Efficacy of dyslipidaemia management before and after intervention stratified by ATP III risk categories
| Characteristic | Preintervention (n=896) | Postintervention (n=862) | P value |
| High-risk group | (n=301) | (n=324) | |
| Reasonable management * | 234 (77.7) | 268 (82.7) | 0.118 |
| Overtreatment | 6 (2%) | 8 (2.5) | 0.688 |
| Undertreatment | 61 (20.3) | 48 (14.8) | 0.073 |
| On target† | 126 (49.4) | 175 (61.0) | 0.007 |
| Moderately high-risk group | (n=68) | (n=87) | |
| Reasonable management * | 64 (94.1) | 79 (90.8) | 0.444 |
| Overtreatment | 3 (4.4) | 5 (5.7) | 0.441 |
| Undertreatment | 1 (1.5) | 3 (3.4) | 0.441 |
| On target† | 29 (70.7) | 31 (70. 5) | 0.978 |
| Moderate-risk group | (n=11) | (n=43) | |
| Reasonable management * | 9 (81.8) | 36 (83.71) | 0.880 |
| Overtreatment | 1 (9.1) | 2 (4.7) | 0.811 |
| Undertreatment | 1 (9.1) | 5 (11.6) | 0.566 |
| On target† | 4 (80.01%) | 6 (50) | 0.252 |
| Low-risk group | (n=516) | (n=408) | |
| Reasonable management * | 445 (86.2) | 380 (93.1) | 0.001 |
| Overtreatment | 65 (12.6) | 24 (5.9) | 0.001 |
| Undertreatment | 6 (1) | 4 (1) | 0.790 |
| On target† | 56 (62.9) | 55 (80.9) | 0.014 |
*Reasonable management means patients on statins who were eligible for this therapy or patients not on statins who were not eligible.
†On target means the LDL-C met the ATP III treatment target; it was calculated in the patients who were eligible for statins.
ATP, Adult Treatment Panel; LDL, low-density lipoprotein.